Patents by Inventor Serge Segot Chicq

Serge Segot Chicq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110104268
    Abstract: A subject-matter of the invention is novel pharmaceutical formulations which make it possible to improve the intestinal absorption of orally administered active principles, their process of preparation and the application of lipid excipients in combination with one or more surfactants and one or more cosurfactants for inhibiting efflux pumps.
    Type: Application
    Filed: August 27, 2010
    Publication date: May 5, 2011
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Jean Pachot, Serge Segot Chicq
  • Patent number: 7732431
    Abstract: The invention concerns a pharmaceutical composition comprises trimegestone optionally associated with an oestrogen, characterized in that it comprises a buffer solution whereof the pH, when it is introduced in the composition, ranging essentially between 2 and 5.5. The invention also concerns the methods for making such a composition and the primary package containing them.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: June 8, 2010
    Assignee: aventis pharma SA
    Inventors: Philippe Becourt, Robert Georges, Serge Segot Chicq
  • Publication number: 20080193519
    Abstract: A subject-matter of the invention is novel pharmaceutical formulations which make it possible to improve the intestinal absorption of orally administered active principles, their process of preparation and the application of lipid excipients in combination with one or more surfactants and one or more cosurfactants for inhibiting efflux pumps.
    Type: Application
    Filed: July 20, 2005
    Publication date: August 14, 2008
    Applicant: Aventis Pharma S.A.
    Inventors: Jean Pachot, Serge Segot Chicq
  • Publication number: 20070219169
    Abstract: The invention concerns a pharmaceutical composition comprises trimegestone optionally associated with an oestrogen, characterized in that it comprises a buffer solution whereof the pH, when it is introduced in the composition, ranging essentially between 2 and 5.5. The invention also concerns the methods for making such a composition and the primary package containing them.
    Type: Application
    Filed: September 18, 2006
    Publication date: September 20, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe Becourt, Robert Georges, Serge Segot Chicq